Does thrombectomy (thrombus removal) 6-24 hours after stroke onset improve functional independence?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Thrombectomy 6-24 Hours After Stroke Onset and Functional Independence

Yes, thrombectomy performed 6-24 hours after stroke onset significantly improves functional independence in carefully selected patients with large vessel occlusion who demonstrate salvageable brain tissue on advanced imaging. 1, 2

Evidence-Based Patient Selection Criteria

The American Heart Association guidelines establish that thrombectomy in the 6-24 hour window requires mandatory perfusion imaging to identify salvageable tissue—this is not optional. 1, 2 Specifically:

  • CT perfusion or diffusion-weighted MRI with perfusion imaging must demonstrate a mismatch between the ischemic core and the area of hypoperfusion 2, 3
  • Patients must have confirmed large vessel occlusion on CTA or MRA 1
  • ASPECTS score ≥6 is required 1, 3
  • NIHSS score ≥6 for eligibility 1
  • Age 18-89 years, though age limits should not be absolute contraindications 1

Magnitude of Benefit

The landmark trials supporting this approach demonstrate substantial improvements in functional outcomes:

  • DAWN trial: 49% achieved functional independence (mRS 0-2) with thrombectomy versus 13% with medical therapy alone—a 33% absolute difference and the largest effect ever described in acute stroke treatment 3, 4
  • DEFUSE-3 trial: 45% achieved functional independence versus 17% with medical therapy alone, with a 28% absolute increase in good outcomes 2, 3, 5
  • The odds ratio for favorable functional outcome was 2.77 in DEFUSE-3 (P<0.001) 5
  • Mortality was reduced from 26% to 14% in the DEFUSE-3 trial 5

Posterior Circulation Considerations

For basilar artery occlusion specifically, the evidence supports an even broader time window:

  • 0-12 hours: Thrombectomy is indicated (Class I, Level B-R) based on the ATTENTION trial, which showed 46% achieved good functional outcome versus 23% with medical therapy 1, 2
  • 12-24 hours: Thrombectomy is reasonable (Class IIa, Level B-R) based on the BAOCHE trial, demonstrating 46% favorable outcomes versus 24% with medical therapy alone 1, 2
  • Patients must have PC-ASPECTS ≥6 1, 2
  • Mortality was significantly lower with thrombectomy (31-37% versus 42-55%) 2

Critical Pitfalls to Avoid

Do not proceed with thrombectomy in the 6-24 hour window without perfusion imaging—tissue selection is mandatory for benefit, and treating patients without demonstrable salvageable tissue exposes them to procedural risks without potential benefit. 2, 3

Do not delay thrombectomy for unnecessary testing—only blood glucose measurement is required before treatment initiation. 2, 3

Do not wait to assess IV thrombolysis response before proceeding to angiography if thrombectomy is being considered. 2

Do not use time alone as the selection criterion—the paradigm has shifted from "time window" to "tissue window," recognizing that individual patients have varying compensatory mechanisms and collateral flow patterns. 4

Technical and Post-Procedural Management

  • The angiographic target should be modified TICI 2b/3 reperfusion to maximize functional outcomes 2, 6, 3
  • Maintain blood pressure ≤180/105 mmHg during and for 24 hours after the procedure 6
  • Symptomatic intracranial hemorrhage rates remain low (5-7%) and are not significantly different from medical therapy alone 2, 5

Time-Dependent Effects Within the Extended Window

Even within the 6-24 hour window, faster treatment correlates with better outcomes, particularly in patients with ASPECTS 8-10. 7 Each 15-minute delay decreases the probability of good functional outcome (adjusted OR 0.98 per 15 minutes). 7 However, this time-dependency is less pronounced in the 6-24 hour window compared to the 0-6 hour window, reinforcing that tissue viability rather than absolute time is the critical determinant. 7

Contraindications in the Extended Window

ASPECTS score of 0 indicates extensive irreversible brain damage and precludes benefit from thrombectomy. 3

Absence of perfusion mismatch indicates no salvageable tissue, making reperfusion unlikely to provide benefit. 3

Time beyond 24 hours for anterior circulation strokes remains outside established therapeutic windows, though posterior circulation (basilar artery) occlusions may be considered on a case-by-case basis (Class IIb, Level C-EO). 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Thrombectomy Outcomes in the 6-24 Hour Window

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Trombectomia em Pacientes com Oclusão de M1

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Endovascular Treatment of Acute Ischemic Stroke.

Continuum (Minneapolis, Minn.), 2020

Guideline

Assessment and Management of Ischemic Stroke with Left M1 Occlusion Status Post Thrombectomy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Stroke Treatment Delay Limits Outcome After Mechanical Thrombectomy: Stratification by Arrival Time and ASPECTS.

Journal of neuroimaging : official journal of the American Society of Neuroimaging, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.